カテゴリ： 世界, 自動車, QYResearch

ヒルシュスプルング病治療の世界市場2023年：抗感染症薬、制吐剤、鎮痛剤

■ 英語タイトル：Global Hirschsprung Disease Treatment Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8787）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8787
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：89
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ヒルシュスプルング病治療の世界市場2023年：抗感染症薬、制吐剤、鎮痛剤]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はヒルシュスプルング病治療のグローバル市場について調査・分析し、世界のヒルシュスプルング病治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（抗感染症薬、制吐剤、鎮痛剤）、用途別セグメント分析（病院、薬局、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Pfizer、Sanofi、Bayer Healthcare、Johnson and Johnson、Merck and Co.、Novartis AG、Bristol-Myers Squibb、Astellas Pharma、Abbott、Cipla Ltd.などが含まれています。ヒルシュスプルング病治療のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ヒルシュスプルング病治療市場規模を算出する際に考慮しました。

・ヒルシュスプルング病治療市場の概要
- ヒルシュスプルング病治療の種類別セグメント
- 世界のヒルシュスプルング病治療市場規模：タイプ別分析（抗感染症薬、制吐剤、鎮痛剤）
- ヒルシュスプルング病治療の用途別セグメント
- 世界のヒルシュスプルング病治療市場規模：用途別分析（病院、薬局、その他）
- 世界のヒルシュスプルング病治療市場規模予測（2018年-2029年）

・ヒルシュスプルング病治療市場の成長トレンド
- ヒルシュスプルング病治療の地域別市場規模（2018年-2029年）
- ヒルシュスプルング病治療市場ダイナミクス
- ヒルシュスプルング病治療の業界動向
- ヒルシュスプルング病治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：抗感染症薬、制吐剤、鎮痛剤
- 世界のヒルシュスプルング病治療のタイプ別市場規模（2018年-2023年）
- 世界のヒルシュスプルング病治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、薬局、その他
- 世界のヒルシュスプルング病治療の用途別市場規模（2018年-2023年）
- 世界のヒルシュスプルング病治療の用途別市場規模（2024年-2029年）

・ヒルシュスプルング病治療の地域別市場規模
- 北米のヒルシュスプルング病治療市場規模（2018年-2029年）
- 米国のヒルシュスプルング病治療市場規模（2018年-2029年）
- ヨーロッパのヒルシュスプルング病治療市場規模（2018年-2029年）
- アジア太平洋のヒルシュスプルング病治療市場規模（2018年-2029年）
- 中国のヒルシュスプルング病治療市場規模（2018年-2029年）
- 日本のヒルシュスプルング病治療市場規模（2018年-2029年）
- 韓国のヒルシュスプルング病治療市場規模（2018年-2029年）
- インドのヒルシュスプルング病治療市場規模（2018年-2029年）
- オーストラリアのヒルシュスプルング病治療市場規模（2018年-2029年）
- 中南米のヒルシュスプルング病治療市場規模（2018年-2029年）
- 中東・アフリカのヒルシュスプルング病治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Pfizer、Sanofi、Bayer Healthcare、Johnson and Johnson、Merck and Co.、Novartis AG、Bristol-Myers Squibb、Astellas Pharma、Abbott、Cipla Ltd.

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Hirschsprung Disease Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Hirschsprung Disease Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Hirschsprung Disease Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Hirschsprung Disease Treatment in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Hirschsprung Disease Treatment include Pfizer, Sanofi, Bayer Healthcare, Johnson and Johnson, Merck and Co., Novartis AG, Bristol-Myers Squibb, Astellas Pharma and Abbott, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hirschsprung Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hirschsprung Disease Treatment.
The Hirschsprung Disease Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hirschsprung Disease Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hirschsprung Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Pfizer
Sanofi
Bayer Healthcare
Johnson and Johnson
Merck and Co.
Novartis AG
Bristol-Myers Squibb
Astellas Pharma
Abbott
Cipla Ltd.
Segment by Type
Anti-Infective Drugs
Antiemetic
Pain Reliever
Segment by Application
Hospital
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hirschsprung Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hirschsprung Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Anti-Infective Drugs
1.2.3 Antiemetic
1.2.4 Pain Reliever
1.3 Market by Application
1.3.1 Global Hirschsprung Disease Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hirschsprung Disease Treatment Market Perspective (2018-2029)
2.2 Hirschsprung Disease Treatment Growth Trends by Region
2.2.1 Global Hirschsprung Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hirschsprung Disease Treatment Historic Market Size by Region (2018-2023)
2.2.3 Hirschsprung Disease Treatment Forecasted Market Size by Region (2024-2029)
2.3 Hirschsprung Disease Treatment Market Dynamics
2.3.1 Hirschsprung Disease Treatment Industry Trends
2.3.2 Hirschsprung Disease Treatment Market Drivers
2.3.3 Hirschsprung Disease Treatment Market Challenges
2.3.4 Hirschsprung Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hirschsprung Disease Treatment Players by Revenue
3.1.1 Global Top Hirschsprung Disease Treatment Players by Revenue (2018-2023)
3.1.2 Global Hirschsprung Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Hirschsprung Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hirschsprung Disease Treatment Revenue
3.4 Global Hirschsprung Disease Treatment Market Concentration Ratio
3.4.1 Global Hirschsprung Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hirschsprung Disease Treatment Revenue in 2022
3.5 Hirschsprung Disease Treatment Key Players Head office and Area Served
3.6 Key Players Hirschsprung Disease Treatment Product Solution and Service
3.7 Date of Enter into Hirschsprung Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hirschsprung Disease Treatment Breakdown Data by Type
4.1 Global Hirschsprung Disease Treatment Historic Market Size by Type (2018-2023)
4.2 Global Hirschsprung Disease Treatment Forecasted Market Size by Type (2024-2029)
5 Hirschsprung Disease Treatment Breakdown Data by Application
5.1 Global Hirschsprung Disease Treatment Historic Market Size by Application (2018-2023)
5.2 Global Hirschsprung Disease Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Hirschsprung Disease Treatment Market Size (2018-2029)
6.2 North America Hirschsprung Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Hirschsprung Disease Treatment Market Size by Country (2018-2023)
6.4 North America Hirschsprung Disease Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hirschsprung Disease Treatment Market Size (2018-2029)
7.2 Europe Hirschsprung Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Hirschsprung Disease Treatment Market Size by Country (2018-2023)
7.4 Europe Hirschsprung Disease Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hirschsprung Disease Treatment Market Size (2018-2029)
8.2 Asia-Pacific Hirschsprung Disease Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Hirschsprung Disease Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Hirschsprung Disease Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hirschsprung Disease Treatment Market Size (2018-2029)
9.2 Latin America Hirschsprung Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Hirschsprung Disease Treatment Market Size by Country (2018-2023)
9.4 Latin America Hirschsprung Disease Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hirschsprung Disease Treatment Market Size (2018-2029)
10.2 Middle East & Africa Hirschsprung Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Hirschsprung Disease Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Hirschsprung Disease Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Hirschsprung Disease Treatment Introduction
11.1.4 Pfizer Revenue in Hirschsprung Disease Treatment Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Hirschsprung Disease Treatment Introduction
11.2.4 Sanofi Revenue in Hirschsprung Disease Treatment Business (2018-2023)
11.2.5 Sanofi Recent Development
11.3 Bayer Healthcare
11.3.1 Bayer Healthcare Company Detail
11.3.2 Bayer Healthcare Business Overview
11.3.3 Bayer Healthcare Hirschsprung Disease Treatment Introduction
11.3.4 Bayer Healthcare Revenue in Hirschsprung Disease Treatment Business (2018-2023)
11.3.5 Bayer Healthcare Recent Development
11.4 Johnson and Johnson
11.4.1 Johnson and Johnson Company Detail
11.4.2 Johnson and Johnson Business Overview
11.4.3 Johnson and Johnson Hirschsprung Disease Treatment Introduction
11.4.4 Johnson and Johnson Revenue in Hirschsprung Disease Treatment Business (2018-2023)
11.4.5 Johnson and Johnson Recent Development
11.5 Merck and Co.
11.5.1 Merck and Co. Company Detail
11.5.2 Merck and Co. Business Overview
11.5.3 Merck and Co. Hirschsprung Disease Treatment Introduction
11.5.4 Merck and Co. Revenue in Hirschsprung Disease Treatment Business (2018-2023)
11.5.5 Merck and Co. Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Detail
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Hirschsprung Disease Treatment Introduction
11.6.4 Novartis AG Revenue in Hirschsprung Disease Treatment Business (2018-2023)
11.6.5 Novartis AG Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Hirschsprung Disease Treatment Introduction
11.7.4 Bristol-Myers Squibb Revenue in Hirschsprung Disease Treatment Business (2018-2023)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Astellas Pharma
11.8.1 Astellas Pharma Company Detail
11.8.2 Astellas Pharma Business Overview
11.8.3 Astellas Pharma Hirschsprung Disease Treatment Introduction
11.8.4 Astellas Pharma Revenue in Hirschsprung Disease Treatment Business (2018-2023)
11.8.5 Astellas Pharma Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Hirschsprung Disease Treatment Introduction
11.9.4 Abbott Revenue in Hirschsprung Disease Treatment Business (2018-2023)
11.9.5 Abbott Recent Development
11.10 Cipla Ltd.
11.10.1 Cipla Ltd. Company Detail
11.10.2 Cipla Ltd. Business Overview
11.10.3 Cipla Ltd. Hirschsprung Disease Treatment Introduction
11.10.4 Cipla Ltd. Revenue in Hirschsprung Disease Treatment Business (2018-2023)
11.10.5 Cipla Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hirschsprung Disease Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Anti-Infective Drugs
Table 3. Key Players of Antiemetic
Table 4. Key Players of Pain Reliever
Table 5. Global Hirschsprung Disease Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Hirschsprung Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Hirschsprung Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Hirschsprung Disease Treatment Market Share by Region (2018-2023)
Table 9. Global Hirschsprung Disease Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Hirschsprung Disease Treatment Market Share by Region (2024-2029)
Table 11. Hirschsprung Disease Treatment Market Trends
Table 12. Hirschsprung Disease Treatment Market Drivers
Table 13. Hirschsprung Disease Treatment Market Challenges
Table 14. Hirschsprung Disease Treatment Market Restraints
Table 15. Global Hirschsprung Disease Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Hirschsprung Disease Treatment Market Share by Players (2018-2023)
Table 17. Global Top Hirschsprung Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hirschsprung Disease Treatment as of 2022)
Table 18. Ranking of Global Top Hirschsprung Disease Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Hirschsprung Disease Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hirschsprung Disease Treatment Product Solution and Service
Table 22. Date of Enter into Hirschsprung Disease Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hirschsprung Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Hirschsprung Disease Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Hirschsprung Disease Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Hirschsprung Disease Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Hirschsprung Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Hirschsprung Disease Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Hirschsprung Disease Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Hirschsprung Disease Treatment Revenue Market Share by Application (2024-2029)
Table 32. North America Hirschsprung Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Hirschsprung Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Hirschsprung Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Hirschsprung Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Hirschsprung Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Hirschsprung Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Hirschsprung Disease Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Hirschsprung Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Hirschsprung Disease Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Hirschsprung Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Hirschsprung Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Hirschsprung Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Hirschsprung Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Hirschsprung Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Hirschsprung Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Pfizer Company Detail
Table 48. Pfizer Business Overview
Table 49. Pfizer Hirschsprung Disease Treatment Product
Table 50. Pfizer Revenue in Hirschsprung Disease Treatment Business (2018-2023) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Sanofi Company Detail
Table 53. Sanofi Business Overview
Table 54. Sanofi Hirschsprung Disease Treatment Product
Table 55. Sanofi Revenue in Hirschsprung Disease Treatment Business (2018-2023) & (US$ Million)
Table 56. Sanofi Recent Development
Table 57. Bayer Healthcare Company Detail
Table 58. Bayer Healthcare Business Overview
Table 59. Bayer Healthcare Hirschsprung Disease Treatment Product
Table 60. Bayer Healthcare Revenue in Hirschsprung Disease Treatment Business (2018-2023) & (US$ Million)
Table 61. Bayer Healthcare Recent Development
Table 62. Johnson and Johnson Company Detail
Table 63. Johnson and Johnson Business Overview
Table 64. Johnson and Johnson Hirschsprung Disease Treatment Product
Table 65. Johnson and Johnson Revenue in Hirschsprung Disease Treatment Business (2018-2023) & (US$ Million)
Table 66. Johnson and Johnson Recent Development
Table 67. Merck and Co. Company Detail
Table 68. Merck and Co. Business Overview
Table 69. Merck and Co. Hirschsprung Disease Treatment Product
Table 70. Merck and Co. Revenue in Hirschsprung Disease Treatment Business (2018-2023) & (US$ Million)
Table 71. Merck and Co. Recent Development
Table 72. Novartis AG Company Detail
Table 73. Novartis AG Business Overview
Table 74. Novartis AG Hirschsprung Disease Treatment Product
Table 75. Novartis AG Revenue in Hirschsprung Disease Treatment Business (2018-2023) & (US$ Million)
Table 76. Novartis AG Recent Development
Table 77. Bristol-Myers Squibb Company Detail
Table 78. Bristol-Myers Squibb Business Overview
Table 79. Bristol-Myers Squibb Hirschsprung Disease Treatment Product
Table 80. Bristol-Myers Squibb Revenue in Hirschsprung Disease Treatment Business (2018-2023) & (US$ Million)
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Astellas Pharma Company Detail
Table 83. Astellas Pharma Business Overview
Table 84. Astellas Pharma Hirschsprung Disease Treatment Product
Table 85. Astellas Pharma Revenue in Hirschsprung Disease Treatment Business (2018-2023) & (US$ Million)
Table 86. Astellas Pharma Recent Development
Table 87. Abbott Company Detail
Table 88. Abbott Business Overview
Table 89. Abbott Hirschsprung Disease Treatment Product
Table 90. Abbott Revenue in Hirschsprung Disease Treatment Business (2018-2023) & (US$ Million)
Table 91. Abbott Recent Development
Table 92. Cipla Ltd. Company Detail
Table 93. Cipla Ltd. Business Overview
Table 94. Cipla Ltd. Hirschsprung Disease Treatment Product
Table 95. Cipla Ltd. Revenue in Hirschsprung Disease Treatment Business (2018-2023) & (US$ Million)
Table 96. Cipla Ltd. Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hirschsprung Disease Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Hirschsprung Disease Treatment Market Share by Type: 2022 VS 2029
Figure 3. Anti-Infective Drugs Features
Figure 4. Antiemetic Features
Figure 5. Pain Reliever Features
Figure 6. Global Hirschsprung Disease Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Hirschsprung Disease Treatment Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Others Case Studies
Figure 11. Hirschsprung Disease Treatment Report Years Considered
Figure 12. Global Hirschsprung Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Hirschsprung Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Hirschsprung Disease Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global Hirschsprung Disease Treatment Market Share by Players in 2022
Figure 16. Global Top Hirschsprung Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hirschsprung Disease Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Hirschsprung Disease Treatment Revenue in 2022
Figure 18. North America Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Hirschsprung Disease Treatment Market Share by Country (2018-2029)
Figure 20. United States Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Hirschsprung Disease Treatment Market Share by Country (2018-2029)
Figure 24. Germany Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Hirschsprung Disease Treatment Market Share by Region (2018-2029)
Figure 32. China Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Hirschsprung Disease Treatment Market Share by Country (2018-2029)
Figure 40. Mexico Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Hirschsprung Disease Treatment Market Share by Country (2018-2029)
Figure 44. Turkey Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Hirschsprung Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Hirschsprung Disease Treatment Business (2018-2023)
Figure 47. Sanofi Revenue Growth Rate in Hirschsprung Disease Treatment Business (2018-2023)
Figure 48. Bayer Healthcare Revenue Growth Rate in Hirschsprung Disease Treatment Business (2018-2023)
Figure 49. Johnson and Johnson Revenue Growth Rate in Hirschsprung Disease Treatment Business (2018-2023)
Figure 50. Merck and Co. Revenue Growth Rate in Hirschsprung Disease Treatment Business (2018-2023)
Figure 51. Novartis AG Revenue Growth Rate in Hirschsprung Disease Treatment Business (2018-2023)
Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Hirschsprung Disease Treatment Business (2018-2023)
Figure 53. Astellas Pharma Revenue Growth Rate in Hirschsprung Disease Treatment Business (2018-2023)
Figure 54. Abbott Revenue Growth Rate in Hirschsprung Disease Treatment Business (2018-2023)
Figure 55. Cipla Ltd. Revenue Growth Rate in Hirschsprung Disease Treatment Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 静脈逆流症治療の世界市場2023年：手術治療、非外科的治療
  • 移植片対宿主病治療の世界市場インサイト・予測（～2028年）
  • ドライアイ疾患用治療装置のグローバル市場展望 2023年-2029年：マイボーム腺詰まり解消器具、涙点閉塞、鎮痛器具、その他
  • 非侵襲的美容治療製品の世界市場2023年：ボトックス/皮膚フィラー、レーザー脱毛器、高周波/超音波器、糸、その他
  • トリメチルアミン尿症治療の世界市場2023年：経口、注射
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8787 )"ヒルシュスプルング病治療の世界市場2023年：抗感染症薬、制吐剤、鎮痛剤" (英文：Global Hirschsprung Disease Treatment Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。